ESPR

NASDAQStock

Esperion Therapeutics, Inc.

$2.42-0.04 (-1.82%)

52-Week Range

$0.73

$4.08

Key Stats

Market Cap

479.0M

P/E Ratio

—

Dividend Yield

—

Beta

1.11

Volume

4.8M

Avg Volume

5.4M

Performance

-27.35%

-34.66%

-11.15%

YTD

-33.42%

+64.67%

-37.94%

-92.03%

Price Chart

ETF Exposure

ESPR is held by 64 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	3,413	$16K	$1.29B	0.17%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	340,218	$21K	$3.91B	0.07%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	20	$51	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	65	$168	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	111	$287	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	127	$330	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	151	$391	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	126	$325	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	83	$214	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	63	$162	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	28	$72	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	370	$2K	$820.6M	0.25%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	63	$293	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	340,218	$69K	$14.63B	0.20%

PreviousPage 2 of 2

About ESPR ETF Exposure

Esperion Therapeutics, Inc. (ESPR) is held by 64 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 479.0M, ESPR is a widely held institutional stock. The stock currently trades at $2.42. Investors can gain exposure to ESPR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ESPR, sorted by portfolio weight.